917 related articles for article (PubMed ID: 29294371)
21. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
Allison KE; Coomber BL; Bridle BW
Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
[TBL] [Abstract][Full Text] [Related]
22. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
24. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
Mathupala SP
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
[TBL] [Abstract][Full Text] [Related]
25. Drugging cancer metabolism: Expectations vs. reality.
Montrose DC; Galluzzi L
Int Rev Cell Mol Biol; 2019; 347():1-26. PubMed ID: 31451211
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of targeting glucose metabolism in glioma stem cells.
Nakano I
Expert Opin Ther Targets; 2014 Nov; 18(11):1233-6. PubMed ID: 25077882
[TBL] [Abstract][Full Text] [Related]
27. Clinical development of cancer therapeutics that target metabolism.
Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
[TBL] [Abstract][Full Text] [Related]
28. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
29. How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard P; Shulman S; Farhat D; Steyaert JM; Alifano M; Lincet H
Drug Resist Updat; 2018 May; 38():1-11. PubMed ID: 29857814
[TBL] [Abstract][Full Text] [Related]
30. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect.
Chen XS; Li LY; Guan YD; Yang JM; Cheng Y
Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491
[TBL] [Abstract][Full Text] [Related]
31. Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy.
Zois CE; Harris AL
J Mol Med (Berl); 2016 Feb; 94(2):137-54. PubMed ID: 26882899
[TBL] [Abstract][Full Text] [Related]
32. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
[TBL] [Abstract][Full Text] [Related]
33. Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism.
Guo X; Wang T; Huang G; Li R; Da Costa C; Li H; Lv S; Li N
Curr Cancer Drug Targets; 2021; 21(7):558-574. PubMed ID: 33949933
[TBL] [Abstract][Full Text] [Related]
34. The promise and peril of targeting cell metabolism for cancer therapy.
Weiss JM
Cancer Immunol Immunother; 2020 Feb; 69(2):255-261. PubMed ID: 31781842
[TBL] [Abstract][Full Text] [Related]
35. Cancer Metabolism as a Therapeutic Target and Review of Interventions.
Halma MTJ; Tuszynski JA; Marik PE
Nutrients; 2023 Oct; 15(19):. PubMed ID: 37836529
[TBL] [Abstract][Full Text] [Related]
36. The challenges and the promise of molecular targeted therapy in malignant gliomas.
Wang H; Xu T; Jiang Y; Xu H; Yan Y; Fu D; Chen J
Neoplasia; 2015 Mar; 17(3):239-55. PubMed ID: 25810009
[TBL] [Abstract][Full Text] [Related]
37. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
Talekar M; Boreddy SR; Singh A; Amiji M
Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma.
Di K; Lomeli N; Wood SD; Vanderwal CD; Bota DA
Oncotarget; 2016 Nov; 7(47):77457-77467. PubMed ID: 27764809
[TBL] [Abstract][Full Text] [Related]
39. Targeting respiratory complex I to prevent the Warburg effect.
Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM
Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477
[TBL] [Abstract][Full Text] [Related]
40. Emerging targeted therapies for glioma.
Miller JJ; Wen PY
Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]